22ND CENTURY GROUP INC (XXII)
NASDAQConsumer StaplesTobaccoSnapshot 2026-09-04
$2.45+7.46%
Close 2026-09-04 · 1-day change
NASDAQConsumer StaplesTobaccoSnapshot 2026-09-04
Intact: The reason to own it still holds.
22nd Century Group aims to reduce nicotine in tobacco, helping public health. It plans a 1-for-20 reverse stock split to keep its stock listed. The company is also pushing a warrant inducement to raise capital. These moves support financial stability despite losses.
The company is losing money with no clear path to profit. Revenue is expected to shrink about 34% next year. Recent termination of a key agreement and multiple equity sales show financial stress. The stock has dropped 90% from its high.
The market expects about a 34% revenue decline and continued losses. Our fair value is around $23.52, reflecting these challenges. The stock price is deeply discounted but the outlook remains weak.
Breaks if: reverse stock split not completed by mid-2026
Breaks if: revenue decline worse than -34% YoY in FY26
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a speculative growth opportunity, as XXII is focused on expanding its product distribution and improving financial metrics. The current thesis state is cautious due to recent volatility and weak results.
The market seems to have priced in a low expectations gap, indicating that investors are not overly optimistic about XXII's near-term performance. Valuation appears cheap compared to peers, but there is a significant divergence in expectations.
Fundamentals are likely to remain under pressure in the near term, as the company has been loss-making with weak recent financial performance. Management's mixed progress on key priorities raises concerns about their ability to improve results.
The thesis hinges on whether management can successfully expand product distribution and improve consumer awareness. Additionally, external factors like inflation and performance of sector bellwethers could influence XXII's trajectory.
The most important moves since the prior daily snapshot.
Mixed, the news cuts both ways. The company announced a strategic shift to expand VLN product distribution. This enhances consumer awareness and aligns with its growth strategy. However, it posted a steep earnings miss, raising concerns about execution.
as of 2026-09-04
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Breaks if: warrant inducement not completed by mid-2026
In the 1 to 3 year view, XXII's outlook is uncertain due to high risk and recent performance issues. Not investment advice.